Search

Your search keyword '"Klauck SM"' showing total 112 results

Search Constraints

Start Over You searched for: Author "Klauck SM" Remove constraint Author: "Klauck SM"
112 results on '"Klauck SM"'

Search Results

1. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.

3. Identification of novel mutations in three families with Emery-Dreifuss muscular dystrophy

4. Mapping autism risk loci using genetic linkage and chromosomal rearrangements

5. GENETIC FLANKING MARKERS REFINE DIAGNOSTIC-CRITERIA AND PROVIDE INSIGHTS INTO THE GENETICS OF VONHIPPEL LINDAU DISEASE

6. Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders

7. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways

8. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

9. Individual common variants exert weak effects on the risk for autism spectrum disorderspi

10. A genome-wide scan for common alleles affecting risk for autism

11. Linkage and candidate gene studies of autism spectrum disorders in European populations

12. Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia

13. A genome-wide linkage and association scan reveals novel loci for autism

14. Mapping autism risk loci using genetic linkage and chromosomal rearrangements

15. A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder

16. The cytotoxic activities of the major diterpene extracted from Salvia multicaulis (Bardakosh) are mediated by the regulation of heat-shock response and fatty acid metabolism pathways in human leukemia cells.

17. Inhibition of MSH6 augments the antineoplastic efficacy of cisplatin in non-small cell lung cancer as autophagy modulator.

18. Aniquinazoline B, a Fungal Natural Product, Activates the μ-Opioid Receptor.

19. Identification of Cytisine Derivatives as Agonists of the Human Delta Opioid Receptor by Supercomputer-Based Virtual Drug Screening and Transcriptomics.

20. Enhancing cisplatin drug sensitivity through PARP3 inhibition: The influence on PDGF and G-coupled signal pathways in cancer.

21. Cytotoxicity of dioncophylline A and related naphthylisoquinolines in leukemia cells, mediated by NF-κB inhibition, angiogenesis suppression, G2/M cell cycle arrest, and autophagy induction.

22. Jozimine A 2 , a Dimeric Naphthylisoquinoline (NIQ) Alkaloid, Shows In Vitro Cytotoxic Effects against Leukemia Cells through NF-κB Inhibition.

23. The cardiac glycoside ZINC253504760 induces parthanatos-type cell death and G2/M arrest via downregulation of MEK1/2 phosphorylation in leukemia cells.

24. Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myeloma.

25. Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells.

26. The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells.

27. Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management.

28. Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling.

29. Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells.

30. Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells.

31. A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells.

32. Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells.

33. Cytotoxicity of 4-hydroxy-N-(naphthalen-1-yl)-2-oxo-2H-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of PERK/eIF2α/ATF4 pathway.

34. Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids.

35. Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validation.

36. DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer.

37. miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells.

38. 2α-Hydroxyalantolactone from Pulicaria undulata: activity against multidrug-resistant tumor cells and modes of action.

39. Multiple modes of cell death in neuroendocrine tumors induced by artesunate.

40. Quantitative genome-wide association study of six phenotypic subdomains identifies novel genome-wide significant variants in autism spectrum disorder.

41. The role of rare compound heterozygous events in autism spectrum disorder.

42. Adaptogens in chemobrain (Part II): Effect of plant extracts on chemotherapy-induced cytotoxicity in neuroglia cells.

43. Adaptogens in chemobrain (Part III): Antitoxic effects of plant extracts towards cancer chemotherapy-induced toxicity - transcriptome-wide microarray analysis of neuroglia cells.

44. Adaptogens in chemobrain (Part I): Plant extracts attenuate cancer chemotherapy-induced cognitive impairment - Transcriptome-wide microarray profiles of neuroglia cells.

45. Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation.

46. Genome-Based Classification and Therapy of Prostate Cancer.

47. Analysis of shared heritability in common disorders of the brain.

48. Common functional variants of the glutamatergic system in Autism spectrum disorder with high and low intellectual abilities.

49. The Chinese herbal formula Free and Easy Wanderer ameliorates oxidative stress through KEAP1-NRF2/HO-1 pathway.

50. TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells.

Catalog

Books, media, physical & digital resources